ArticleGastroenterology research and practice2010
Henoch-schonlein purpura-a case report and review of the literature.
Article in Gastroenterology research and practice, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 108 citations in OpenAlex.
- Trial
- Review
- First case of IgA vasculitis atypically presenting as recurrent gastroenteritis from Nepal: a case report and review of the literature.Annals of medicine and surgery (2012) · 2026Article
- Article
- Terminal ileitis: a rare gastrointestinal manifestation of IgA vasculitis in a child.BMJ case reports · 2024Article
- Delayed diagnosis of abdominal Henoch-Schonlein purpura in children: A case report.World journal of clinical cases · 2023Article
- Intravenous immunoglobulin therapy in immunoglobulin A vasculitis with gastrointestinal tract involvement.Clinical and experimental medicine · 2023Article
- Henoch-Schönlein purpura in the setting of COVID-19 infection: Two pediatrics cases and review of the literature.Journal of family medicine and primary care · 2023Review
- How to differentiate between Eosinophilic Granulomatous Polyangiitis and Henoch-Schönlein Purpura.Mediterranean journal of rheumatology · 2022Article
- Henoch-Schonlein purpura due to sodium valproate: A case report.Clinical case reports · 2022Article
- A Case Series of Adult Patients Diagnosed with IgA Vasculitis Requiring Systemic Immunosuppression.The American journal of case reports · 2021Article
- Terminal Ileitis as the Presenting Feature of Henoch-Schönlein Purpura in a 22-Year-Old Male.Cureus · 2021Article
- Deficiency in the frequency and function of Tr1 cells in IgAV and the possible role of IL-27.Rheumatology (Oxford, England) · 2021Article
- Article
- A child with Henoch-Schonlein purpura secondary to a COVID-19 infection.BMJ case reports · 2021Article
- Article
- Article
- Seizures, renal failure and acute respiratory failure: not your typical case of Henoch-Schonlein purpura.BMJ case reports · 2019Article
- Observational
- Diagnosis and treatment of adult mixed-type Henoch-Schönlein purpura.Central-European journal of immunology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We describe a case of an adolescent male with Henoch-Schonlein purpura (HSP), presenting with cutaneous and gastrointestinal manifestations. Endoscopy revealed diffuse ulcerations in the stomach, duodenum, and right colon. Biopsies revealed a leukocytoclastic vasculitis in the skin and gastrointestinal tract. Steroid therapy led to complete resolution of the symptoms. HSP is the most common childhood vasculitis, and is characterized by the classic tetrad of nonthrombocytopenic palpable purpura, arthritis or arthralgias, gastrointestinal and renal involvement. It is a systemic disease where antigen-antibody (IgA) complexes activate the alternate complement pathway, resulting in inflammation and small vessel vasculitis. Mild disease resolves spontaneously, and symptomatic treatment alone is sufficient. Systemic steroids are recommended for moderate to severe HSP. The prognosis depends upon the extent of renal involvement, which requires close followup. Early recognition of multiorgan involvement, especially outside of the typical age group, as in our adolescent patient, and appropriate intervention can mitigate the disease and limit organ damage.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.